AU2006322460A1 - Stable solid formulation of sertindole - Google Patents

Stable solid formulation of sertindole Download PDF

Info

Publication number
AU2006322460A1
AU2006322460A1 AU2006322460A AU2006322460A AU2006322460A1 AU 2006322460 A1 AU2006322460 A1 AU 2006322460A1 AU 2006322460 A AU2006322460 A AU 2006322460A AU 2006322460 A AU2006322460 A AU 2006322460A AU 2006322460 A1 AU2006322460 A1 AU 2006322460A1
Authority
AU
Australia
Prior art keywords
pharmaceutical composition
solid pharmaceutical
sertindole
coating layer
protective agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2006322460A
Other languages
English (en)
Inventor
Anne Ravnholdt Christensen
Ken Liljegren
Flemming Enok Olsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
H Lundbeck AS
Original Assignee
H Lundbeck AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck AS filed Critical H Lundbeck AS
Publication of AU2006322460A1 publication Critical patent/AU2006322460A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2006322460A 2005-09-08 2006-09-06 Stable solid formulation of sertindole Abandoned AU2006322460A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200501255 2005-09-08
DKPA200501255 2005-09-08
PCT/DK2006/050038 WO2007065448A1 (en) 2005-09-08 2006-09-06 Stable solid formulation of sertindole

Publications (1)

Publication Number Publication Date
AU2006322460A1 true AU2006322460A1 (en) 2007-06-14

Family

ID=37697999

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2006322460A Abandoned AU2006322460A1 (en) 2005-09-08 2006-09-06 Stable solid formulation of sertindole

Country Status (17)

Country Link
EP (1) EP1924261A1 (ko)
JP (1) JP2009507051A (ko)
KR (1) KR20080042102A (ko)
CN (1) CN101257906A (ko)
AR (1) AR056475A1 (ko)
AU (1) AU2006322460A1 (ko)
BR (1) BRPI0615630A2 (ko)
CA (1) CA2621866A1 (ko)
EA (1) EA013167B1 (ko)
IL (1) IL189541A0 (ko)
MX (1) MX2008002290A (ko)
NO (1) NO20081721L (ko)
NZ (1) NZ565330A (ko)
TW (1) TW200738239A (ko)
UA (1) UA97349C2 (ko)
WO (1) WO2007065448A1 (ko)
ZA (1) ZA200801169B (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI320783B (en) 2005-04-14 2010-02-21 Otsuka Pharma Co Ltd Heterocyclic compound
CN106344533A (zh) * 2009-01-29 2017-01-25 大日本住友制药株式会社 具有内核的口腔崩解片剂
FR2943061B1 (fr) * 2009-03-13 2011-02-25 Rhodia Operations Composes organophosphores, systemes catalytiques comprenant ces composes et procede d'hydrocyanation ou d'hydroformylation utilisant ces systemes catalytiques
LT2872488T (lt) 2012-07-16 2018-10-25 Fibrogen, Inc. Kristalinės prolilhidroksilazės inhibitoriaus formos
US8883823B2 (en) 2012-07-16 2014-11-11 Fibrogen, Inc. Crystalline forms of a prolyl hydroxylase inhibitor
ES2786924T3 (es) * 2013-06-06 2020-10-14 Fibrogen Inc Formulaciones farmacéuticas que comprenden un inhibidor de hidroxilasa del HIF
EP3043793B1 (en) * 2013-11-19 2021-01-06 Siga Technologies Inc. Rehydration of micronized tecovirimat monohydrate
JP2018172361A (ja) * 2016-10-14 2018-11-08 大原薬品工業株式会社 光安定性を改善した、デュロキセチンを含有する固形製剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04346929A (ja) * 1991-05-22 1992-12-02 Takada Seiyaku Kk 光に安定なメシル酸ブロモクリプチン製剤
WO1997035584A1 (en) * 1996-03-25 1997-10-02 Eli Lilly And Company Method for treating pain
ZA973433B (en) * 1996-04-24 1997-12-10 Shionogi & Co A sertindole-containing preparation and a method for producing the same.
ZA977967B (en) * 1996-09-23 1999-03-04 Lilly Co Eli Combination therapy for treatment of psychoses

Also Published As

Publication number Publication date
EP1924261A1 (en) 2008-05-28
EA200800774A1 (ru) 2008-06-30
IL189541A0 (en) 2008-08-07
NO20081721L (no) 2008-04-08
UA97349C2 (uk) 2012-02-10
ZA200801169B (en) 2010-07-28
MX2008002290A (es) 2008-03-14
JP2009507051A (ja) 2009-02-19
CA2621866A1 (en) 2007-06-14
BRPI0615630A2 (pt) 2016-11-16
CN101257906A (zh) 2008-09-03
TW200738239A (en) 2007-10-16
NZ565330A (en) 2011-06-30
KR20080042102A (ko) 2008-05-14
EA013167B1 (ru) 2010-02-26
AR056475A1 (es) 2007-10-10
WO2007065448A1 (en) 2007-06-14

Similar Documents

Publication Publication Date Title
AU2006322460A1 (en) Stable solid formulation of sertindole
TWI262079B (en) Controlled release Galantamine formulation
CA2476054C (en) Pharmaceutical composition for the oral administration of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino)-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino)-propionic acid ethyl ester and the salts thereof
US6537573B2 (en) Combination dosage form comprising cetirizine and pseudoephedrine
ES2273790T3 (es) Composicion farmaceutica de liberacion sostenida.
JP6487599B2 (ja) エスシタロプラム医薬組成物
EP1720527A2 (en) A stable pharmaceutical composition comprising an acid labile drug
MX2008014758A (es) Formulaciones de liberacion retardada de clorhidrato de duloxetina.
JP6364406B2 (ja) 口腔内崩壊錠
AU2005257977A1 (en) Stable pharmaceutical formulations of benzimidazole compounds
EA030433B1 (ru) Энтеросолюбильная таблетка
US20070141150A1 (en) Pharmaceutical composition
AU719075B2 (en) Controlled release pharmaceutical compositions for the oral administration containing nifedipine as active substance
RU2593771C2 (ru) Энтеросолюбильная таблетка
GB2098867A (en) Sustained release pharmaceutical composition
EP2293782B1 (en) Stable benzimidazole formulation
US20070212412A1 (en) Stable solid formulation of sertindole
US4411882A (en) Galenical compositions
TW201832762A (zh) 一種含有癒創木酚甘油醚的劑型組成及其應用
JP6739289B2 (ja) ゲフィチニブを有効成分とする医薬錠剤の製造方法
WO2003077829A2 (en) Process for preparation of a pharmaceutical composition containing acid labile compounds
CN106668018B (zh) 一种右兰索拉唑钠的缓释胶囊及其制备方法
JP2004231520A (ja) 保存安定性及び溶出速度に優れた医薬組成物
JP2020066634A (ja) 腸溶性高分子及び崩壊剤を含有する顆粒
REDDY et al. FORMULATION AND EVALUATION OF DULOXETINE HYDROCHLORIDE DELAYED RELEASE ENTERIC COATED CAPSULES PREETHI MYLAVARAPU1, PRATHIMA SRINIVAS*, VENKATA

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application